Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

SHE:301089 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,395	3,567	6,835	9,072	10,130	-
Market Cap Growth	-28.53%	-47.81%	-24.66%	-10.45%	-	-
Enterprise Value	4,117	3,210	6,483	8,682	10,148	-
Last Close Price	34.73	28.19	53.66	71.15	79.45	-
PE Ratio	-	-	28.12	31.66	154.17	-
PS Ratio	10.71	8.46	8.18	11.56	20.16	-
PB Ratio	2.84	2.30	4.26	6.59	9.23	-
P/TBV Ratio	2.99	2.43	4.50	7.02	10.00	-
P/FCF Ratio	-	190.19	-	75.28	-	-
P/OCF Ratio	195.22	34.75	253.57	33.74	174.08	-
EV/Sales Ratio	10.03	7.61	7.76	11.06	20.20	-
EV/EBITDA Ratio	-	518.42	18.72	24.93	88.37	-
EV/EBIT Ratio	-	-	21.63	28.21	120.93	-
EV/FCF Ratio	-72.71	171.12	-	72.04	-	-
Debt / Equity Ratio	0.00	0.00	-	0.03	0.06	0.36
Debt / EBITDA Ratio	7.33	0.65	-	0.11	0.60	1.11
Debt / FCF Ratio	-	0.23	-	0.33	-	3.83
Asset Turnover	0.23	0.23	0.45	0.49	0.43	0.63
Inventory Turnover	1.55	1.62	1.64	1.62	1.92	2.09
Quick Ratio	2.73	2.98	3.02	1.81	2.39	0.60
Current Ratio	4.14	4.10	4.23	2.39	3.13	0.99
Return on Equity (ROE)	-1.62%	-1.26%	16.32%	23.17%	8.28%	25.81%
Return on Assets (ROA)	-1.66%	-1.43%	10.17%	11.89%	4.48%	10.45%
Return on Capital (ROIC)	-1.88%	-1.63%	12.41%	14.89%	5.72%	14.37%
Return on Capital Employed (ROCE)	-	-	18.20%	21.70%	7.40%	26.80%
Earnings Yield	-0.58%	-0.56%	3.56%	3.16%	0.65%	-
FCF Yield	-1.29%	0.53%	-2.32%	1.33%	-0.54%	-
Dividend Yield	0.72%	-	0.47%	0.56%	0.13%	-
Payout Ratio	-	-	20.85%	5.23%	12.05%	8.51%
Buyback Yield / Dilution	-6.46%	1.32%	0.22%	-26.78%	-5.03%	-0.59%
Total Shareholder Return	-5.74%	1.32%	0.69%	-26.22%	-4.91%	-0.59%

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.